DeviceSpace.com
Medical Device and Diagnostics
News & Jobs
 
Search the Site
    
 
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login           Employers:  Register | Login  
 News | News By Subject | News By Date | Search News
Get Our Industry eNewsletter FREE email:    
 Print  Email    

Cynosure, Inc. (CYNO) Announces Upcoming Conference Presentations


2/7/2012 8:29:24 AM

WESTFORD, Mass., Feb. 6, 2012 /PRNewswire/ -- Cynosure, Inc. (NASDAQ: CYNO), a leader in laser- and light-based treatments for minimally invasive and non-invasive aesthetic applications, today announced that President and Chief Executive Officer Michael Davin and Executive Vice President, Treasurer and Chief Financial Officer Timothy Baker will present at two upcoming investor conferences.

On Wednesday, February 15 at 4:00 p.m. (ET), management will give a brief presentation followed by a fireside chat at the Leerink Swann 2012 Global Healthcare Conference in New York City.

On Tuesday, February 28 at 8:30 a.m. (ET), management will present at the Citi 2012 Global Healthcare Conference in New York City.

To access the live or archived webcasts of these events, visit the "Investor Relations" portion of Cynosure's website, www.cynosure.com.

About Cynosure, Inc.
Cynosure, Inc. develops and markets aesthetic treatment systems that are used by physicians and other practitioners to perform non-invasive and minimally invasive procedures to remove hair, treat vascular and pigmented lesions, rejuvenate the skin, liquefy and remove unwanted fat through laser lipolysis, reduce the appearance of cellulite and treat Onychomycosis. Cynosure's products include a broad range of laser and other light-based energy sources, including Alexandrite, pulse dye, Q-switched, Nd:YAG and diode lasers, as well as intense pulsed light. Cynosure was founded in 1991. For corporate or product information, contact Cynosure at 800-886-2966, or visit www.cynosure.com.

Contact:
Scott Solomon
Vice President
Sharon Merrill Associates, Inc.
617.542.5300
cyno@investorrelations.com

SOURCE Cynosure, Inc.


Read at BioSpace.com


 Read Article at  Related Companies  News Categories
   


ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 
    

//-->